# Treatment of Failing Blebs With Ranibizumab

> **NCT00570726** · PHASE1 · COMPLETED · sponsor: **The New York Eye & Ear Infirmary** · enrollment: 6 (estimated)

## Conditions studied

- Glaucoma, Open-Angle
- Failing Bleb Following Trabeculectomy

## Interventions

- **DRUG:** Ranibizumab (Lucentis)

## Key facts

- **NCT ID:** NCT00570726
- **Lead sponsor:** The New York Eye & Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2014-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00570726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00570726, "Treatment of Failing Blebs With Ranibizumab". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00570726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*